Tom Bailey is a board member of SCP Interventional Radiology, a Shore Capital portfolio company. Tom joined NanoString Technologies as CFO in January 2018. He was formerly the CFO of Agamatrix and previously served as President and CEO for Angiotech Pharmaceuticals, Inc. until the fall of 2013, at which time he transitioned to Angiotech’s board. As CEO of Angiotech, Tom led the company through a successful operational restructuring, and concluded the sale of one of Angiotech’s two medical device products businesses, generating significant returns for Angiotech’s shareholders. Prior to being named Angiotech’s CEO in the fall of 2011, Tom served for six years as Angiotech’s CFO, and for two years as its Vice President of Business Development. Prior to Angiotech, Tom worked as an investment banker in the life sciences practice group at Credit Suisse First Boston and Donaldson, Lufkin & Jenrette.
He holds an A.B. in Economics from Harvard University, and also received his MBA from Harvard Business School.